LAB International to hold its annual general meeting of shareholders June 22, 2007 in Montreal
    Toronto Stock Exchange Symbol: LAB

    MONTREAL, June 19 /CNW Telbec/ - LAB International Inc. (TSX: LAB,
Frankfurt: LD9.F, XETRA: LD9.DE) ("LAB"), a drug development company focused
on developing therapies for the inhalation and pain markets, today announced
that it will host its Annual General Meeting of Shareholders on Friday
June 22, 2007. The Annual Meeting will be held at the Centre Sheraton in
Montreal, 1201 René-Lévesque Blvd. West at 2.00pm in the Salon Hemon.

    Live Webcast:

    For those who are unable to attend in person, the Company will
simultaneously webcast the event in the Investor Relations section at

    About LAB International

    LAB International is an integrated drug development company focused on
the growing multi-billion dollar inhalation market. Its lead product, for the
treatment of breakthrough cancer pain, is a fast-acting Fentanyl formulation
delivered using the Company's TAIFUN(R) dry powder inhaler platform. Its
pipeline also includes therapeutics for asthma, COPD, and growth hormone
    LAB's common shares trade on The Toronto Stock Exchange ("TSX") under the
symbol "LAB", on the Frankfurt Regulated Unofficial Market under the symbol
"LD9.F" and on XETRA under the symbol "LD9.DE" with 82.3 million shares

    This news release contains certain forward-looking statements that
reflect the current views and/or expectations of LAB International Inc. with
respect to its performance, business and future events. Such statements are
subject to a number of risks, uncertainties and assumptions. Actual results
and events may vary significantly.
    %SEDAR: 00003466EF

For further information:

For further information: visit LAB's website at, or
contact: Frédéric Dumais, Vice-President, Investor Relations, (514) 315-3330,
ext. 106, Fax: (514) 315-3325,

Organization Profile

Akela Pharma Inc

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890